Evommune Inc.
EVMN | NYSE
$6.75
+$0.02 (+0.30%)
Nov 2, 2026, 9:30 AM ET · Market open
Market Data
Market Cap $244.97M
Enterprise Value $51.56M
Beta 0.96
Average Volume 912.46K
Shares Outstanding (Diluted) 36.14M
Shares Change YoY 20.14%
Institutional Ownership 96.08%
Exchange NYSE
ISIN US30054Y1073
Price Performance
Price Change 1M -2.5%
Price Change 3M -41.8%
Price Change 6M -71.4%
Price Change YTD -60.6%
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -30.3%
1Y CAGR (ann.) N/A
5Y CAGR (ann.) N/A
All-Time CAGR -67.4%
Valuation
PE Ratio -2.38
Forward PE N/A
PEG Ratio 0.05
Forward PEG 0.07
PS Ratio 24.42
Forward PS 1,099.10
PB Ratio 0.88
P/FCF Ratio -3.27
P/Adj. FCF Ratio -3.08
P/OCF Ratio -3.28
EV/Sales 5.16
EV/EBIT -0.53
EV/EBITDA -0.54
EV/FCF -0.69
Earnings Yield -42.0%
FCF Yield -30.6%
Adj. FCF Yield -32.5%
Financial Health
Net Cash $200.79M
Total Debt $8.11M
Cash & Short-Term Investments $200.79M
Total Assets $301.95M
Current Ratio 11.68
Quick Ratio 11.68
Debt / Equity Ratio 0.03
Debt / EBITDA -0.08
Debt / FCF -0.11
OCF / Debt -9.14
Interest Coverage 0.00
Altman Z-Score 4.45
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -1018.9%
EBITDA Margin -1003.5%
Net Profit Margin -946.7%
FCF Margin -746.5%
Adj. FCF Margin -792.5%
SBC / Revenue 128.1%
SBC Impact (per share) -6.2%
Returns
Return on Assets -31.4%
Return on Equity -62.6%
Return on Invested Capital -35.7%
Return on Capital Employed -35.8%
Return on Tangible Assets -31.4%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y -15.8%
Revenue Growth Next 3Y -33.1%
Earnings Date Oct 16, 2026
EPS Estimate (next Q) -$0.82
EPS Growth Est (next Q) 82.2%
Revenue Est (next Q) $500K
Revenue Growth Est (next Q) -95.0%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $25.00
Price Target Upside 271.5%
Cash Flow
Operating Cash Flow $-74.15M
Free Cash Flow $-74.65M
Adj. Free Cash Flow $-79.25M
FCF Per Share -$2.07
OCF Per Share -$2.05
OCF/S Ratio -741.5%
Income Statement
Revenue $10M
Gross Profit $9.65M
Operating Income $-101.89M
EBITDA $-95.78M
Net Income $-94.67M
EPS (Diluted) -$2.83
Revenue / Employee $208.33K
Profit / Employee $-1.97M
Employees 48
Add to Watchlist
Select watchlists to add or remove EVMN